Načítá se...
Immunization for meningococcal serogroup B: What does the practitioner need to know?
Most invasive meningococcal disease in Canada is now caused by serogroup B organisms. A vaccine directed against this serogroup (4CMenB) is newly licensed in Canada. A decision will need to be made by all provinces and territories regarding whether a routine infant immunization program is warranted....
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Pulsus Group Inc
2014
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3941677/ https://ncbi.nlm.nih.gov/pubmed/24596484 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|